A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
Conditions
Interventions
- DRUG: emtricitabine 200mg/tenofovir 300mg
Sponsor
University of California, Los Angeles
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]